NASDAQ: PMDPsychemedics Corp Stock
$2.57+0.01 (+0.39%)
Updated Apr 19, 2024
PMD Price
$2.57
Fair Value Price
-$0.58
Market Cap
$14.76M
52 Week Low
$2.06
52 Week High
$5.59
P/E
-3.57x
P/B
2.21x
P/S
0.77x
PEG
N/A
Dividend Yield
2.72%
Revenue
$22.10M
Earnings
-$4.15M
Gross Margin
38.1%
Operating Margin
-15.56%
Profit Margin
-18.8%
Debt to Equity
0.85
Operating Cash Flow
-$1M
Beta
0.47
Next Earnings
May 7, 2024
Ex-Dividend
N/A
Next Dividend
N/A
PMD Overview
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opiates, such as heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine and Fentanyl. Its testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. The company offers its services to employers for applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was incorporated in 1986 and is headquartered in Acton, Massachusetts.
Zen Score
–
Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PMD scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PMD ($2.57) is overvalued by 540.8% relative to our estimate of its Fair Value price of -$0.58 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
PMD ($2.57) is not significantly undervalued (540.8%) relative to our estimate of its Fair Value price of -$0.58 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
PMD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more PMD due diligence checks available for Premium users.
Be the first to know about important PMD news, forecast changes, insider trades & much more!
PMD News
Valuation
PMD fair value
Fair Value of PMD stock based on Discounted Cash Flow (DCF)
Price
$2.57
Fair Value
-$0.58
Undervalued by
540.80%
PMD ($2.57) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
PMD ($2.57) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
PMD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
PMD price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-3.57x
Industry
36.14x
Market
40.51x
PMD price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.21x
Industry
4.01x
PMD is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
PMD's financial health
Profit margin
Revenue
$5.0M
Net Income
-$945.0k
Profit Margin
-18.9%
PMD's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
PMD's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$12.3M
Liabilities
$5.7M
Debt to equity
0.85
PMD's short-term assets ($6.81M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PMD's short-term assets ($6.81M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PMD's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
PMD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$662.0k
Investing
$5.0k
Financing
-$73.0k
PMD's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
PMD vs Diagnostic & Research Stocks
Psychemedics Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.